Abstract
Children requiring noninvasive and invasive chronic ventilator support are frequently prescribed therapeutic aerosols. Little guidance is available regarding the optimal ways of delivering aerosol to these children. In addition to the frequently reported factors that affect drug delivery, this population poses several challenges. The presence of humid/heated air and the passage through artificial and ventilator circuits are some of the factors that can hinder aerosol delivery. Most of the pediatric data are based on in vitro experiments and few animal studies. We will discuss the currently available data and provide suggested best practice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Willis D, Berlinski A. Survey of aerosol delivery techniques to spontaneously breathing tracheostomized children. Respir Care. 2012;57(8):1234–41.
Sherman JM, Davis S, Albamonte-Petrick S, Chatburn RL, Fitton C, Green C, et al. Care of the child with a chronic tracheostomy. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161(1):297–308.
O’Callaghan C, Dryden S, Cert DN, Gibbin K. Asthma therapy and a tracheostomy. J Laryngol Otol. 1989;103(4):427–8.
Subhedar NV, Doyle C, Shaw NJ. Administration of inhaled medication via a tracheostomy in infants with chronic lung disease of prematurity. Pediatr Rehabil. 1999;3(2):41–2.
Monksfield P. Modification of a spacer device for paediatric tracheostomy. Clin Otolaryngol. 2008;33(2):193–4.
Baran D, Dachy A, Klastersky J. Concentration of gentamicin in bronchial secretions of children with cystic fibrosis or tracheostomy. Int J Clin Pharmacol Biopharm. 1975;12(3):336–41.
Palmer LB, Smaldone GC, Simon SR, O’Riordan TG, Cuccia A. Aerosolized antibiotics in mechanically ventilated patients: delivery and response. Crit Care Med. 1998;26(1):31–9.
Rusakow LS, Guarin M, Wegner CB, Rice TB, Mischler EH. Suspected respiratory tract infection in the tracheostomized child. Chest. 1998;113(6):1549–54.
Hamer DH. Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant pseudomonas aeruginosa with aerosolized colistin. Am J Respir Crit Care Med. 2000;162(1):328–30.
Falagas ME, Sideri G, Korbila IP, Vouloumanou EK, Papadatos JH, Kafetzis DA. Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis. Pediatr Pulmonol. 2010;45(11):1135–40.
Hendriks T, de Hoog M, Lequin MH, Devos AS, Merkus PJFM. DNase and atelectasis in non-cystic fibrosis pediatric patients. Crit Care. 2005;9(4):R351–6.
Salyer JW, Chatburn RL. Patterns of practice in neonatal and pediatric respiratory care. Respir Care. 1990;35(9):879–88.
Laube BL, Janssens HM, de Jongh FH, Devadason SG, Dhand R, Diot P, Everard ML, Horvath I, Navalesi P, Voshaar T, Chrystyn H, European Respiratory Society, International Society for Aerosols in Medicine. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37(6):1308–31.
Dhand R. Aerosol delivery during mechanical ventilation: from basic techniques to new devices. J Aerosol Med Pulm Drug Deliv. 2008;21(1):45–60.
Dhand R. Aerosol therapy in patients receiving noninvasive positive pressure ventilation. J Aerosol Med Pulm Drug Deliv. 2012;25(2):63–78.
Dolovich MB, Dhand R. Aerosol drug delivery: developments in device design and clinical use. Lancet. 2011;377(9770):1032–45.
Laube BL, Jashnani R, Dalby RN, Zeitlin PL. Targeting aerosol deposition in patients with cystic fibrosis: effects of alterations in particle size and inspiratory flow rate. Chest. 2000;118(4):1069–76.
Clay MM, Pavia D, Newman SP, Lennard-Jones T, Clarke SW. Assessment of jet nebulisers for lung aerosol therapy. Lancet. 1983;2(8350):592–4.
Alvine GF, Rodgers P, Fitzsimmons KM, Ahrens RC. Disposable jet nebulizers. How reliable are they? Chest. 1992;101(2):316–9.
Hess D, Fisher D, Williams P, Pooler S, Kacmarek RM. Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand. Chest. 1996;110(2):498–505.
Kradjan WA, Lakshminarayan S. Efficiency of air compressor-driven nebulizers. CHEST. 1985;87:512–6.
Rau JL. Design principles of liquid nebulization devices currently in use. Respir Care. 2002;47(11):1275–8; discussion 1275–278.
Waldrep JC, Dhand R. Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation. Curr Drug Deliv. 2008;5(2):114–9.
Berlinski A, Waldrep JC. Effect of aerosol delivery system and formulation on nebulized Budesonide output. J Aerosol Medicine. 1997;10(4):307–18.
Geller DE. New liquid aerosol generation devices: systems that force pressurized liquids through nozzles. Respir Care. 2002;47(12):1392–404; discussion 1404–5.
Dellweg D, Wachtel H, Höhn E, Pieper MP, Barchfeld T, Köhler D, Glaab T. In vitro validation of a Respimat® adapter for delivery of inhaled bronchodilators during mechanical ventilation. J Aerosol Med Pulm Drug Deliv. 2011;24(6):285–92.
García Pachón E, Casan P, Sanchís J. Bronchodilators through tracheostomy. Med Clin (Barc). 1992;99(10):396–7 [Article in Spanish].
Everard ML, Devadason SG, Le Souëf PN. In vitro assessment of drug delivery through an endotracheal tube using a dry powder inhaler delivery system. Thorax. 1996;51(1):75–7.
Johnson DC. Interfaces to connect the handihaler and aerolizer powder inhalers to a tracheostomy tube. Respir Care. 2007;52(2):166–70.
Young PM, Sung A, Traini D, Kwok P, Chiou H, Chan HK. Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhaler carrier based systems. Pharm Res. 2007;24(5):963–70.
Everard ML. Ethical aspects of using radiolabelling in aerosol research. Arch Dis Child. 2003;88(8):659–61.
O’Callaghan C, Hardy J, Stammers J, Stephenson TJ, Hull D. Evaluation of techniques for delivery of steroids to lungs of neonates using a rabbit model. Arch Dis Child. 1992;67(1Spec No):20–4.
Goldstein I, Wallet F, Nicolas-Robin A, Ferrari F, Marquette CH, Rouby JJ. Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets. Am J Respir Crit Care Med. 2002;166(10):1375–81.
Ferrari F, Liu ZH, Lu Q, Becquemin MH, Louchahi K, Aymard G, Marquette CH, Rouby JJ. Comparison of lung tissue concentrations of nebulized ceftazidime in ventilated piglets: ultrasonic versus vibrating plate nebulizers. Intensive Care Med. 2008;34(9):1718–23.
Berlinski A, Holt S, Thurman T, Heulitt M. Albuterol delivery during mechanical ventilation in an ex-vivo porcine model. J Aerosol Med Pulm Drug Deliv. 2013;26(2):57.
Fink JB, Dhand R, Grychowski J, Fahey PJ, Tobin MJ. Reconciling in vitro and in vivo measurements of aerosol delivery from a metered-dose inhaler during mechanical ventilation and defining efficiency-enhancing factors. Am J Respir Crit Care Med. 1999;159(1):63–8.
Miller DD, Amin MM, Palmer LB, Shah AR, Smaldone GC. Aerosol delivery and modern mechanical ventilation: in vitro/in vivo evaluation. Am J Respir Crit Care Med. 2003;168(10):1205–9.
Watterberg KL, Clark AR, Kelly W, Murphy S. Delivery of aerosolized medication to intubated babies. Pediatr Pulmonol. 1991;10:136–41.
Coleman DM, Kelly HW, McWilliams BC. Determinants of aerosolized albuterol delivery to mechanically ventilated infants. Chest. 1996;109:1607–13.
Garner SS, Wiest DB, Bradley JW. Albuterol delivery by metered-dose inhaler with a pediatric mechanical ventilatory circuit model. Pharmacotherapy. 1994;14(2):210–4.
Wildhaber JH, Hayden MJ, Dore ND, Devadason SG, LeSouëf PN. Salbutamol delivery from a hydrofluoroalkane pressurized metered-dose inhaler in pediatric ventilator circuits: an in vitro study. Chest. 1998;113(1):186–91.
Ari A, Areabi H, Fink JB. Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult mechanical ventilation. Respir Care. 2010;55(7):837–44.
Berlinski A, Waldrep JC. Metering performance of several metered-dose inhalers with different spacers/holding chambers. J Aerosol Medicine. 2001;14(4):427–32.
Diot P, Morra L, Smaldone GC. Albuterol delivery in a model of mechanical ventilation. Comparison of metered-dose inhaler and nebulizer efficiency. Am J Respir Crit Care Med. 1995;152(4 Pt 1):1391–4.
Garner SS, Wiest DB, Bradley JW. Albuterol delivery by metered-dose inhaler in mechanically ventilated pediatric lung model. Crit Care Med. 1996;24(5):870–4.
Habib DM, Garner SS, Brandeburg S. Effect of helium-oxygen on delivery of albuterol in a pediatric, volume-cycled, ventilated lung model. Pharmacotherapy. 1999;19(2):143–9.
Garner SS, Wiest DB, Stevens CE, Habib DM. Effect of heliox on albuterol delivery by metered-dose inhaler in pediatric in vitro models of mechanical ventilation. Pharmacotherapy. 2006;26(10):1396–402.
Sidler-Moix AL, Dolci U, Berger-Gryllaki M, Pannatier A, Cotting J, Di Paolo ER. Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers. Pediatr Crit Care Med. 2013;14(2):e98–102.
Taylor RH, Lerman J. High-efficiency delivery of salbutamol with a metered-dose inhaler in narrow tracheal tubes and catheters. Anesthesiology. 1991;74(2):360–3.
Mitchell JP, Nagel MW, Wiersema KJ, Doyle CC, Migounov VA. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study. Respir Care. 2003;48(11):1025–32.
Cole CH, Mitchell JP, Foley MP, Nagel MW. Hydrofluoroalkane-beclomethasone versus chlorofluorocarbon-beclomethasone delivery in neonatal models. Arch Dis Child Fetal Neonatal Ed. 2004;89(5):F417–8.
Taylor RH, Lerman J, Chambers C, Dolovich M. Dosing efficiency and particle-size characteristics of pressurized metered-dose inhaler aerosols in narrow catheters. Chest. 1993;103(3):920–4.
Fink JB, Dhand R, Duarte AG, Jenne JW, Tobin MJ. Aerosol delivery from a metered-dose inhaler during mechanical ventilation. An in vitro model. Am J Respir Crit Care Med. 1996;154(2 Pt 1):382–7.
Mouloudi E, Katsanoulas K, Anastasaki M, Askitopoulou E, Georgopoulos D. Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of end-inspiratory pause. Eur Respir J. 1998;12(1):165–9.
Mouloudi E, Prinianakis G, Kondili E, Georgopoulos D. Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of flow pattern. Eur Respir J. 2000;16(2):263–8.
Berlinski A, Willis RJ. Albuterol delivery by 4 different nebulizers placed in 4 different positions in a pediatric ventilator circuit. Respir Care. 2013;58(7):1124–33.
Berlinski A, Willis JR. Albuterol delivery by intrapulmonary percussive ventilator and jet nebulizer in a pediatric ventilator model. Respir Care. 2010;55(12):1699–704.
Ari A, Atalay OT, Harwood R, Sheard MM, Aljamhan EA, Fink JB. Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation. Respir Care. 2010;55(7):845–51.
O’Riordan TG, Greco MJ, Perry RJ, Smaldone GC. Nebulizer function during mechanical ventilation. Am Rev Respir Dis. 1992;145(5):1117–22.
Di Paolo ER, Pannatier A, Cotting J. In vitro evaluation of bronchodilator drug delivery by jet nebulization during pediatric mechanical ventilation. Pediatr Crit Care Med. 2005;6(4):462–9.
Ahrens RC, Ries RA, Popendorf W, Wiese JA. The delivery of therapeutic aerosols through endotracheal tubes. Pediatr Pulmonol. 1986;2(1):19–26.
Beaty CD, Ritz RH, Benson MS. Continuous in-line nebulizers complicate pressure support ventilation. Chest. 1989;96(6):1360–3.
Hanhan U, Kissoon N, Payne M, Taylor C, Murphy S, De Nicola LK. Effects of in-line nebulization on preset ventilator variables. Respir Care. 1993;38:474–8.
McPeck M, O’Riordan TG, Smaldone GC. Choice of Mechanical ventilator: influence on nebulizer performance. Respir Care. 1993;38(8):887–95.
Garner SS, Wiest DB, Bradley JW, Habib DM. Two administration methods for inhaled salbutamol in intubated patients. Arch Dis Child. 2002;87(1):49–53.
Ari A, Harwood R, Sheard M, Fink JB. An in-vitro evaluation of aerosol delivery through tracheostomy and endotracheal tubes using different interfaces. Respir Care. 2012;57(7):1066–70.
Berlinski A, Chavez A. Albuterol delivery via metered dose inhaler in a spontaneously breathing pediatric tracheostomy model. Pediatr Pulmonol. 2012;48(10):1026–34.
Chavez A, Holt S, Heulitt M, Berlinski A. Albuterol delivery Via MDI/spacer in a spontaneously breathing pediatric tracheostomy model: does bagging improve drug delivery? Am J Respir Crit Care Med. 2011;183:3383.
Piccuito CM, Hess DR. Albuterol delivery via tracheostomy tube. Respir Care. 2005;50(8):1071–6.
Chavez A, McCraken A, Berlinski A. Effect of face mask static dead volume, respiratory rate and tidal volume on inhaled albuterol delivery. Pediatr Pulmonol. 2010;45(3):224–9.
Berlinski A. In-vitro nebulized albuterol delivery in a model of spontaneously breathing children with tracheostomy. Respir Care. 2013;58(12):2076–86.
Pitance L, Vecellio L, Delval G, Reychler G, Reychler H, Liistro G. Aerosol delivery through tracheostomy tubes: an in vitro study. J Aerosol Med Pulm Drug Deliv. 2013;26(2):76–83.
DiBlasi RM, Coppolo DP, Nagel MW, Doyle CC, Avvakoumova VI, Ali RS, Mitchell JP. A novel, versatile valved holding chamber for delivering inhaled medications to neonates and small children: laboratory simulation of delivery options. Respir Care. 2010;55(4):419–26.
Branconnier MP, Hess DR. Albuterol delivery during noninvasive ventilation. Respir Care. 2005;50(12):1649–53.
Calvert LD, Jackson JM, White JA, Barry PW, Kinnear WJ, O’Callaghan C. Enhanced delivery of nebulised salbutamol during non-invasive ventilation. J Pharm Pharmacol. 2006;58(11):1553–7.
Chatmongkolchart S, Schettino GP, Dillman C, Kacmarek RM, Hess DR. In vitro evaluation of aerosol bronchodilator delivery during noninvasive positive pressure ventilation: effect of ventilator settings and nebulizer position. Crit Care Med. 2002;30(11):2515–9.
Abdelrahim ME, Plant P, Chrystyn H. In-vitro characterisation of the nebulized dose during non-invasive ventilation. J Pharm Pharmacol. 2010;62(8):966–72.
White CC, Crotwell DN, Shen S, Salyer J, Yung D, Diblasi RM. Bronchodilator delivery during simulated pediatric noninvasive ventilation. Respir Care. 2013;58(9):1459–66.
Dai B, Kang J, Sun LF, Tan W, Zhao HW. Influence of exhalation valve and nebulizer position on albuterol delivery during noninvasive positive pressure ventilation. J Aerosol Med Pulm Drug Deliv. 2014;27(2):125–32.
Michotte JB, Jossen E, Roeseler J, Liistro G, Reychler G. In vitro comparison of 5 nebulizers during noninvasive ventilation: analysis of inhaled and lost doses. J Aerosol Med Pulm Drug Deliv. 2014;27(6):430–40.
Chua HL, Collis GG, Newbury AM, Chan K, Bower GD, Sly PD, Le Souef PN. The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J. 1994;7(12):185–91.
Parkes SN, Bersten AD. Aerosol kinetics and bronchodilator efficacy during continuous positive airway pressure delivered by face mask. Thorax. 1997;52(2):171–5.
Fauroux B, Itti E, Pigeot J, Isabey D, Meignan M, Ferry G, Lofaso F, Willemot JM, Clément A, Harf A. Optimization of aerosol deposition by pressure support in children with cystic fibrosis: an experimental and clinical study. Am J Respir Crit Care Med. 2000;162(6):2265–71.
França EE, Dornelas de Andrade AF, Cabral G, Almeida Filho P, Silva KC, Galindo Filho VC, Marinho PE, Lemos A, Parreira VF. Nebulization associated with bi-level noninvasive ventilation: analysis of pulmonary radioaerosol deposition. Respir Med. 2006;100(4):721–8.
Reychler G, Leal T, Roeseler J, Thys F, Delvau N, Liistro G. Effect of continuous positive airway pressure combined to nebulization on lung deposition measured by urinary excretion of amikacin. Respir Med. 2007;101(10):2051–5.
Brandao DC, Lima VM, Filho VG, Silva TS, Campos TF, Dean E, de Andrade AD. Reversal of bronchial obstruction with bi-level positive airway pressure and nebulization in patients with acute asthma. J Asthma. 2009;46(4):356–61.
Abdelrahim ME, Plant PK, Chrystyn H. The relative lung and systemic bioavailability of terbutaline following nebulisation in non-invasively ventilated patients. Int J Pharm. 2011;420(2):313–8.
Galindo-Filho VC, Brandão DC, Ferreira Rde C, Menezes MJ, Almeida-Filho P, Parreira VF, Silva TN, Rodrigues-Machado Mda G, Dean E, Dornelas de Andrade A. Noninvasive ventilation coupled with nebulization during asthma crises: a randomized controlled trial. Respir Care. 2013;58(2):241–9.
Mouloudi E, Katsanoulas K, Anastasaki M, Hoing S, Georgopoulos D. Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of tidal volume. Intensive Care Med. 1999;25(11):1215–21.
Amirav I, Newhouse MT. Review of optimal characteristics of face-masks for valved-holding chambers (VHCs). Pediatr Pulmonol. 2008;43(3):268–74.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Berlinski, A. (2016). Inhaled Drug Delivery for Children on Long-term Mechanical Ventilation. In: Sterni, L., Carroll, J. (eds) Caring for the Ventilator Dependent Child. Respiratory Medicine. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3749-3_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3749-3_11
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3747-9
Online ISBN: 978-1-4939-3749-3
eBook Packages: MedicineMedicine (R0)